Connect with us

archive

The Red-Hot Sector Beating the S&P 500 by Three to One

Biotechnology is a high-octane sector where fortunes are made and lost quickly.

That??s because investing in biotech stocks is a lot like investing in small-cap mining stocks or Silicon Valley start-ups. You have to kiss a lot of investment frogs before you find your ??Prince? Google or Facebook.

Biotechnology has had four massive, triple-digit percentage gain bull markets since the 1980s. The two biggest ones were, first, in the early 1990s, when biotech stocks soared almost 10-fold. The second came later during the dot-com boom, when the Nasdaq Biotechnology Index rose 457% from the end of August 1998 to the end of February 2000. But having been burned by dozens of investments that ??went south,? investors never regained the enthusiasm for biotech they once had in the 1990s.

To read the rest of this article, click here.

Newsletter Signup.

Sign up to the Human Events newsletter

Written By

Nicolas A. Vardy is the London-based International Economics Correspondent for Human Events.

Advertisement
Advertisement

TRENDING NOW:

Today a Milkshake, Tomorrow A Brick: Corporate-Backed Political Violence Is Here.

CULTURE

The Lived Experience of Candace Owens.

CULTURE

Jan Brewer: Trump’s Immigration Plan is Pragmatic

U.S. POLITICS

Buzzfeed Bashes 14-Yr-Old Trump Fan, Celebrates Kids in Drag.

TECH

archive

The Red-Hot Sector Beating the S&P 500 by Three to One

Biotechnology is a high-octane sector where fortunes are made and lost quickly.

That’s because investing in biotech stocks is a lot like investing in small-cap mining stocks or Silicon Valley start-ups. You have to kiss a lot of investment frogs before you find your “Prince” Google or Facebook.

Biotechnology has had four massive, triple-digit percentage gain bull markets since the 1980s. The two biggest ones were, first, in the early 1990s, when biotech stocks soared almost 10-fold. The second came later during the dot-com boom, when the Nasdaq Biotechnology Index rose 457% from the end of August 1998 to the end of February 2000. But having been burned by dozens of investments that “went south,” investors never regained the enthusiasm for biotech they once had in the 1990s.

To read the rest of this article, click here.

Newsletter Signup.

Sign up to the Human Events newsletter

TRENDING NOW:

Today a Milkshake, Tomorrow A Brick: Corporate-Backed Political Violence Is Here.

CULTURE

The Lived Experience of Candace Owens.

CULTURE

Jan Brewer: Trump’s Immigration Plan is Pragmatic

U.S. POLITICS

Buzzfeed Bashes 14-Yr-Old Trump Fan, Celebrates Kids in Drag.

TECH

Connect
Newsletter Signup.

Sign up to the Human Events newsletter